Dynamics of the structure of renal tuberculosis over 20 years

Cover Page

Cite item

Full Text

Abstract

Background. Tuberculosis is a serious medical and social problem that does not lose its importance, despite all the advances in pharmacology and surgery. Diagnosis of urogenital tuberculosis (UGTB), as a rule, is delayed due to low index of suspicion to tuberculosis and the absence of pathognomonic symptoms.

Aim. Determining the change in the ratio of clinical forms of renal tuberculosis from 1999 to 2020.

Materials and methods. A retrospective cohort comparative non-interventional study on the spectrum of the incidence of extrapulmonary tuberculosis (EPTB) was carried out. Among all 13852 extrapulmonary tuberculosis patients which were diagnosed from 1999 to 2020, patients with renal tuberculosis were selected, and the spectrum of their clinical forms in three periods was analyzed: 1st period 1999–2004 (1155 patients), second period 2005–2014 (2657 patients), and the third period 2015–2020 (671 patients). The clinical features of nephrotuberculosis in 88 patients was also estimated.

Results. Over the 20 years of the analyzed period, the number of patients with UGTB decreased by 80.6%; for the year of the COVID-19 pandemic, this figure fell by another third. In the first period, destructive complicated forms of nephrotuberculosis prevailed (922 patients – 79.8%), while the so-called "minor forms" were diagnosed in 233 patients (20.2%). In the second period, the situation was statistically significantly more favorable: the proportion of destructive and complicated forms of renal tuberculosis decreased to 43.8% (1124 patients), "small forms" were diagnosed in 1443 patients (56.2%). In the third period, destructive and complicated forms of nephrotuberculosis were diagnosed in 531 patients (77.6%), and the proportion of "small forms" in comparison with the previous period decreased by half, to 22.4%. Analysis of the clinical features of renal tuberculosis, depending on the prevalence of the destruction, showed that an asymptomatic course is possible, and pain, dysuria, intoxication and renal colic are present with different frequencies, and the clinical picture of tuberculosis of the renal parenchyma differs significantly from the clinical picture of tuberculous papillitis, cavernous nephrotuberculosis and symptoms of renal tuberculosis as whole.

Conclusion. Currently, there is no screening on urogenital tuberculosis at all. Patients are diagnosed by referral, with a long history, after receiving multiple courses of antibacterial treatment; mainly through the pathomorphological examination of the operating material. Thus, a sharp decrease in the proportion of UGTB patients does not mean the disappearance of tuberculosis of this localization, but only states the tragic defects in timely diagnosis and low index of suspicion of medical doctors in relation to UGTB.

About the authors

Ekaterina V. Kulchavenya

Novosibirsk Tuberculosis Research Institute; Novosibirsk State Medical University

Author for correspondence.
Email: urotub@yandex.ru
ORCID iD: 0000-0001-8062-7775
https://www.researchgate.net/profile/Ekaterina_Kulchavenya

Doctor of Medical Science, Professor, Chief Researcher, Head of the Urology Department of Novosibirsk Research Institute of Tuberculosis, Professor of the Department of Tuberculosis, Novosibirsk State Medical University

Russian Federation, Novosibirsk; Novosibirsk

Denis P. Kholtobin

Novosibirsk Tuberculosis Research Institute; Medical Center "Avicenna"

Email: urotub@yandex.ru
ORCID iD: 0000-0001-6645-6455

канд. мед. наук, ст. науч. сотр., рук. урологической клиники

Russian Federation, Novosibirsk; Novosibirsk

References

  1. World Health Organization. Global Tuberculosis Report. Executive Summary; 2019. Available at: https://www.who.int/tb/publications/global_report/GraphicExecutiveSummary.pdf?ua=1. Accessed: 18.11.2022.
  2. World Health Organization. TB disease burden. In: Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
  3. Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond). 2020;52(12):902-7. doi: 10.1080/23744235.2020.1806353
  4. Осадчий А.В., Кульчавеня Е.В., Рейхруд Т.А., и др. Социально-демографическая характеристика больных туберкулезом легких и внелегочных локализаций. Туберкулез и болезни легких. 2015;2:46-8 [Osadchiy AV, Kulchavenya EV, Reykhrud TA, et al. Socio-demographic characteristics of patients with pulmonary tuberculosis and extrapulmonary localizations. Tuberculosis and Lung Diseases. 2015;2:46-8 (in Russian)]. doi: 10.21292/2075-1230-2015-0-2-46-49
  5. Щербань М.Н., Кульчавеня Е.В., Брижатюк Е.В. Диагностика, предупреждение и лечение нарушений репродуктивной функции у мужчин, больных туберкулезом легких. Туберкулез и болезни легких. 2010;87(10):31-6 [Shcherban MN, Kulchavenya EV, Brizhatyuk EV. Diagnostics, prevention and treatment of reproductive disorders in men with pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2010;87(10):31-6 (in Russian)].
  6. Benbella A, Aboulmakarim S, Hardizi H, et al. Infertility in the Moroccan population: major risk factors encountered in the reproductive health centre in Rabat. Pan Afr Med J. 2018;30:195. doi: 10.11604/pamj.2018.30.195.13849
  7. Кульчавеня Е.В., Жукова И.И. Внелегочный туберкулез – вопросов больше, чем ответов. Туберкулез и болезни легких. 2017;95(2):59-63 [Kulchavenya EV, Zhukova II. Extrapulmonary tuberculosis – there are more questions than answers. Tuberculosis and Lung Diseases. 2017;95(2):59-63 (in Russian)]. doi: 10.21292/2075-1230-2017-95-2-59-63
  8. Arnedo-Pena A, Romeu-Garcia MA, Meseguer-Ferrer N, et al. Pulmonary Versus Extrapulmonary Tuberculosis Associated Factors: A Case-Case Study. Microbiol Insights. 2019;12:1178636119840362. doi: 10.1177/1178636119840362
  9. Ahasan HA, Bala CS. Hurdles in management of extrapulmonary tuberculosis. J Bangladesh Coll Phys Surg. 2016;34(4):182-3. doi: 10.3329/jbcps.v34i4.32406
  10. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642-56. doi: 10.1016/S0140-6736(19)30308-3
  11. Кульчавеня Е.В., Брижатюк Е.В., Хомяков В.Т. Туберкулез экстраторакальных локализаций в Сибири и на Дальнем Востоке. Проблемы туберкулеза и болезней легких. 2005;6(82):23-6 [Kulchavenya EV, Brizhatyuk EV, Khomyakov VT. Tuberculosis of extrathoracic localizations in Siberia and the Far East. Problems of Tuberculosis and Lung Disease. 2005;6(82):23-6 (in Russian)].
  12. Figueiredo AA, Lucon AM, Srougi M. Urogenital Tuberculosis. Microbiol Spectr. 2017;5(1). doi: 10.1128/microbiolspec
  13. Gilpin C, Korobitsyn A, Migliori GB, et al. The World Health Organization standards for tuberculosis care and management. Eur Respir J. 2018;51(3):1800098. doi: 10.1183/13993003.00098-2018
  14. Hsieh HC, Lu PL, Chen YH, et al. Urogenital tuberculosis in a medical center in southern Taiwan: An eleven-year experience. J Microbiol Immunol Infect. 2006;39:408-13.
  15. Huang TY, Hung CH, Hsu WH, et al. Genitourinary tuberculosis in Taiwan: a 15-year experience at a teaching hospital. J Microbiol Immunol Infect. 2019;52(2):312-9. doi: 10.1016/j.jmii.2018.10.007
  16. Шевченко С.Ю., Кульчавеня Е.В. Есть ли скрининг для мочеполового туберкулеза? Урология. 2017;6:15-7 [Shevchenko SYu, Kulchavenya EV. Is there a screening for genitourinary tuberculosis? Urologiia. 2017;6:15-7 (in Russian)].
  17. Грунд В.Д. Ошибки в диагностике и лечении туберкулеза мочеполовой системы. М.: Медицина, 1975 [Grund VD. Oshibki v diagnostike i lechenii tuberkuleza mochepolovoi sistemy. Moscow: Meditsinа, 1975 (in Russian)].
  18. Шевченко С.Ю., Кульчавеня Е.В. Информативность пробы с диаскинтестом в скрининге мочеполового туберкулеза. Туберкулез и болезни легких. 2017;95(8):49-51 [Shevchenko SYu, Kulchavenya EV. Informativeness of the test with diaskintest in the screening of urogenital tuberculosis. Tuberculosis and Lung Diseases. 2017;95(8):49-51 (in Russian)]. doi: 10.21292/2075-1230-2017-95-8-49-51
  19. Bedi N, Rahimi MNC, Menzies S, Kalsi J. Atypical testicular pain. BMJ Case Rep. 2019;12(2):e226697. doi: 10.1136/bcr-2018-226697
  20. Kulchavenya E, Kholtobin D. Diseases masking and delaying the diagnosis of urogenital tuberculosis. Ther Adv Urol. 2015;7:331-8. doi: 10.1177/1756287215592604
  21. Banerji JS. Primary tuberculosis of the glans penis in an immunocompetent male. Lancet Infect Dis. 2020;20(4):509. doi: 10.1016/S1473-3099(19)30753-4
  22. Benbella A, Aboulmakarim S, Hardizi H, et al. Infertility in the Moroccan population: an etiological study in the reproductive health centre in Rabat. Pan Afr Med J. 2018;30(6):204. doi: 10.11604/pamj.2018.30.204.13498
  23. Khanna A, Agrawal A. Markers of genital tuberculosis in infertility. Singapore Med J. 2011;52:864-7.
  24. Kulchavenya E, Naber K, Bjerklund Johansen TE. Urogenital tuberculosis: Classification, diagnosis, and treatment. Eur Urol Suppl. 2016;15(4):112-21. doi: 10.1016/j.eursup.2016.04.001
  25. Gambhir S, Ravina M, Rangan K, et al; International Atomic Energy Agency Extra-pulmonary TB Consortium. Imaging in extrapulmonary tuberculosis. Int J Infect Dis. 2017;56:237-47. doi: 10.1016/j.ijid.2016.11.003
  26. Gaudiano C, Tadolini M, Busato F, et al. Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay. Abdom Radiol (NY). 2017;42(9):2314-24. doi: 10.1007/s00261-017-1129-0
  27. Коган М.И., Набока Ю.Л., Ибишев Х.С., Гудима И.А. Нестерильность мочи здорового человека – новая парадигма в медицине. Урология. 2014;5:48-52 [Kogan MI, Naboka YuL, Ibishev HS, Gudima IA. Non-sterility of the urine of a healthy person is a new paradigm in medicine. Urologiia. 2014;5:48-52 (in Russian)].
  28. Gutierrez C. Benefits and challenges of molecular diagnostics for childhood tuberculosis. Int J Mycobacteriol. 2016;5 Suppl. 1:S4-S5. doi: 10.1016/j.ijmyco.2016.08.011
  29. Chen Y, Wu P, Fu L, et al. Multicentre evaluation of Xpert MTB/RIF assay in detecting urinary tract tuberculosis with urine samples. Sci Rep. 2019;9(1):11053. doi: 10.1038/s41598-019-47358-3
  30. Decroo T, Henríquez-Trujillo AR, De Weggheleire A, Lynen L. Rational use of Xpert testing in patients with presumptive TB: Clinicians should be encouraged to use the test-treat threshold. BMC Infect Dis. 2017;17(1):674. doi: 10.1186/s12879-017-2798-6
  31. Atherton RR, Cresswell FV, Ellis J, et al. Detection of Mycobacterium tuberculosis in urine by Xpert MTB/RIF Ultra: A useful adjunctive diagnostic tool in HIV-associated tuberculosis. Int J Infect Dis. 2018;75:92-4. doi: 10.1016/j.ijid.2018.07.007
  32. Broger T, Nicol MP, Székely R, et al. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data. PLoS Med. 2020;17(5):e1003113. doi: 10.1371/journal.pmed.1003113
  33. Shekar PA, Kumar PS. Microbiological diagnosis in urogenital tuberculosis: the Holy Grail still Eludes. World J Urol. 2021;39(9):3693-4. doi: 10.1007/s00345-020-03293-x
  34. Supriyadi R, Darmawan G, Pranggono EH. Renal tuberculosis: The Masquerader. Acta Med Indones. 2019;51(4):353-5.
  35. Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary tuberculosis: pathophysiology and imaging findings. Radiographics. 2019;39(7):2023-37. doi: 10.1148/rg.2019190109
  36. Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis – epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019;16(10):573-98. doi: 10.1038/s41585-019-0228-9
  37. Mosina N, Kayukov I. Renal tuberculosis following BCG therapy for bladder cancer. QJM. 2020;113(3):230-1. doi: 10.1093/qjmed/hcz262
  38. Eswarappa M, HJ GD, John MM, et al. Tuberculosis in renal transplant recipients: Our decade long experience with an opportunistic invader. Indian J Tuberc. 2020;67(1):73-8. doi: 10.1016/j.ijtb.2019.05.001
  39. Almeida APF, Silva DFD, Petruccelli KCS, et al. Urogenital tuberculosis in a patient with end-stage renal disease. Rev Soc Bras Med Trop. 2020;53:e20190284. doi: 10.1590/0037-8682-0284-2019

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The number of patients with urinary tuberculosis in dynamics.

Download (123KB)
3. Fig. 2. Polycavernous nephrotuberculosis with pronounced fibrous transformation.

Download (233KB)
4. Fig. 3. Polycavernous nephrotuberculosis with abundant caseous cavernous contents, stage 4 bladder tuberculosis with microcystis formation.

Download (229KB)
5. Fig. 4. Polycavernous nephrotuberculosis – multiple cavities with caseous contents.

Download (229KB)
6. Fig. 5. Dynamics of the structure of renal tuberculosis.

Download (88KB)
7. Fig. 6. Spectrum of complaints in patients with isolated renal tuberculosis, n=88.

Download (88KB)

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies